249 related articles for article (PubMed ID: 21239842)
1. Fluoride excess and periostitis in transplant patients receiving long-term voriconazole therapy.
Wermers RA; Cooper K; Razonable RR; Deziel PJ; Whitford GM; Kremers WK; Moyer TP
Clin Infect Dis; 2011 Mar; 52(5):604-11. PubMed ID: 21239842
[TBL] [Abstract][Full Text] [Related]
2. Voriconazole-induced periostitis causing arthralgias mimicking a flare of granulomatosis with polyangiitis.
Gladue HS; Fox DA
J Clin Rheumatol; 2013 Dec; 19(8):444-5. PubMed ID: 24263147
[TBL] [Abstract][Full Text] [Related]
3. A case of periostitis secondary to voriconazole therapy in a heart transplant recipient.
Wise SM; Wilson MA
Clin Nucl Med; 2011 Mar; 36(3):242-4. PubMed ID: 21285691
[TBL] [Abstract][Full Text] [Related]
4. Multifocal nodular periostitis associated with prolonged voriconazole therapy in a lung transplant recipient.
Ayub A; Kenney CV; McKiernan FE
J Clin Rheumatol; 2011 Mar; 17(2):73-5. PubMed ID: 21169844
[TBL] [Abstract][Full Text] [Related]
5. Fluoride excess in coccidioidomycosis patients receiving long-term antifungal therapy: an assessment of currently available triazoles.
Thompson GR; Bays D; Cohen SH; Pappagianis D
Antimicrob Agents Chemother; 2012 Jan; 56(1):563-4. PubMed ID: 22005993
[TBL] [Abstract][Full Text] [Related]
6. Periostitis secondary to prolonged voriconazole therapy in lung transplant recipients.
Wang TF; Wang T; Altman R; Eshaghian P; Lynch JP; Ross DJ; Belperio JA; Weigt SS; Saggar R; Gregson A; Kubak B; Saggar R
Am J Transplant; 2009 Dec; 9(12):2845-50. PubMed ID: 19845595
[TBL] [Abstract][Full Text] [Related]
7. Multifocal periostitis as a complication of chronic use of voriconazole in a lung transplant recipient.
Tedja R; El-Sherief A; Olbrych T; Gordon S
Transpl Infect Dis; 2013 Aug; 15(4):424-9. PubMed ID: 23663268
[TBL] [Abstract][Full Text] [Related]
8. Fluorosis and periostitis deformans as complications of prolonged voriconazole treatment.
Rad B; Saleem M; Grant S; Florkowski C; Coates P; Gordon D; Rankin W
Ann Clin Biochem; 2015 Sep; 52(Pt 5):611-4. PubMed ID: 25587196
[TBL] [Abstract][Full Text] [Related]
9. Periostitis secondary to prolonged voriconazole therapy in a lung transplant recipient.
Lustenberger DP; Granata JD; Scharschmidt TJ
Orthopedics; 2011 Nov; 34(11):e793-6. PubMed ID: 22049971
[TBL] [Abstract][Full Text] [Related]
10. Photo quiz. Generalized pain in a 20-year-old man with chronic granulomatous disease.
Launay E; Thomas C; Gras-Le Guen C; Geffroy L; Moreau A; Lortholary O
Clin Infect Dis; 2013 Aug; 57(4):562-3, 616-7. PubMed ID: 23881728
[No Abstract] [Full Text] [Related]
11. Fluorosis because of prolonged voriconazole therapy in a teenager with acute myelogenous leukemia.
Skiles JL; Imel EA; Christenson JC; Bell JE; Hulbert ML
J Clin Oncol; 2011 Nov; 29(32):e779-82. PubMed ID: 21969513
[No Abstract] [Full Text] [Related]
12. Clinical images: voriconazole-induced periostitis deformans.
Becce F; Malghem J; Lecouvet FE; Vande Berg BC; Omoumi P
Arthritis Rheum; 2012 Oct; 64(10):3490. PubMed ID: 22777747
[No Abstract] [Full Text] [Related]
13. Plasma fluoride level as a predictor of voriconazole-induced periostitis in patients with skeletal pain.
Moon WJ; Scheller EL; Suneja A; Livermore JA; Malani AN; Moudgal V; Kerr LE; Ferguson E; Vandenberg DM
Clin Infect Dis; 2014 Nov; 59(9):1237-45. PubMed ID: 24992954
[TBL] [Abstract][Full Text] [Related]
14. Reversible skeletal disease and high fluoride serum levels in hematologic patients receiving voriconazole.
Gerber B; Guggenberger R; Fasler D; Nair G; Manz MG; Stussi G; Schanz U
Blood; 2012 Sep; 120(12):2390-4. PubMed ID: 22859610
[TBL] [Abstract][Full Text] [Related]
15. Adverse reactions to voriconazole.
Boyd AE; Modi S; Howard SJ; Moore CB; Keevil BG; Denning DW
Clin Infect Dis; 2004 Oct; 39(8):1241-4. PubMed ID: 15486850
[TBL] [Abstract][Full Text] [Related]
16. Voriconazole-induced periostitis in two post-transplant patients.
Bucknor MD; Gross AJ; Link TM
J Radiol Case Rep; 2013 Aug; 7(8):10-7. PubMed ID: 24421948
[TBL] [Abstract][Full Text] [Related]
17. Correlation of Pain and Fluoride Concentration in Allogeneic Hematopoietic Stem Cell Transplant Recipients on Voriconazole.
Barajas MR; McCullough KB; Merten JA; Dierkhising RA; Bartoo GT; Hashmi SK; Hogan WJ; Litzow MR; Patnaik MM; Wilson JW; Wolf RC; Wermers RA
Biol Blood Marrow Transplant; 2016 Mar; 22(3):579-83. PubMed ID: 26524731
[TBL] [Abstract][Full Text] [Related]
18. Multifocal squamous cell carcinomas in an HIV-infected patient with a long-term voriconazole therapy.
Brunel AS; Fraisse T; Lechiche C; Pinzani V; Mauboussin JM; Sotto A
AIDS; 2008 Apr; 22(7):905-6. PubMed ID: 18427212
[No Abstract] [Full Text] [Related]
19. Increased incidence of cutaneous squamous cell carcinoma in lung transplant recipients taking long-term voriconazole.
Feist A; Lee R; Osborne S; Lane J; Yung G
J Heart Lung Transplant; 2012 Nov; 31(11):1177-81. PubMed ID: 22841559
[TBL] [Abstract][Full Text] [Related]
20. Long-term visual safety of voriconazole in adult patients with paracoccidioidomycosis.
Laties AM; Fraunfelder FT; Tomaszewski K; Goodrich J; Moreira AT; Sato MT; de Queiroz-Telles F
Clin Ther; 2010 Dec; 32(13):2207-17. PubMed ID: 21316537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
